JP2013527842A5 - - Google Patents

Download PDF

Info

Publication number
JP2013527842A5
JP2013527842A5 JP2013505470A JP2013505470A JP2013527842A5 JP 2013527842 A5 JP2013527842 A5 JP 2013527842A5 JP 2013505470 A JP2013505470 A JP 2013505470A JP 2013505470 A JP2013505470 A JP 2013505470A JP 2013527842 A5 JP2013527842 A5 JP 2013527842A5
Authority
JP
Japan
Prior art keywords
methylsulfonamido
pyridine
methyl
carboxamide
furo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013505470A
Other languages
English (en)
Japanese (ja)
Other versions
JP5756850B2 (ja
JP2013527842A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/056304 external-priority patent/WO2011131709A1/en
Publication of JP2013527842A publication Critical patent/JP2013527842A/ja
Publication of JP2013527842A5 publication Critical patent/JP2013527842A5/ja
Application granted granted Critical
Publication of JP5756850B2 publication Critical patent/JP5756850B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013505470A 2010-04-21 2011-04-20 フロピリジン化合物およびその使用 Expired - Fee Related JP5756850B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32649110P 2010-04-21 2010-04-21
US61/326,491 2010-04-21
PCT/EP2011/056304 WO2011131709A1 (en) 2010-04-21 2011-04-20 Furopyridine compounds and uses thereof

Publications (3)

Publication Number Publication Date
JP2013527842A JP2013527842A (ja) 2013-07-04
JP2013527842A5 true JP2013527842A5 (https=) 2014-05-08
JP5756850B2 JP5756850B2 (ja) 2015-07-29

Family

ID=44010017

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013505470A Expired - Fee Related JP5756850B2 (ja) 2010-04-21 2011-04-20 フロピリジン化合物およびその使用

Country Status (9)

Country Link
US (1) US8324239B2 (https=)
EP (1) EP2560976B9 (https=)
JP (1) JP5756850B2 (https=)
CN (1) CN103025738B (https=)
AR (1) AR082453A1 (https=)
ES (1) ES2605039T3 (https=)
TW (1) TW201139446A (https=)
UY (1) UY33348A (https=)
WO (1) WO2011131709A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013004655A (es) 2010-10-26 2013-08-27 Presidio Pharmaceuticals Inc Inhibidores del virus de la hepatitis c.
WO2013163466A1 (en) * 2012-04-25 2013-10-31 Presidio Pharmaceuticals, Inc. Inhibitors of hepatitis c virus
TWI731854B (zh) * 2015-03-23 2021-07-01 美商共結晶製藥公司 C型肝炎病毒聚合酶之抑制劑
BR112017023821A2 (pt) 2015-05-06 2018-07-31 Leidos Biomedical Res Inc moduladores de k-ras
BR112019021899A2 (pt) 2017-04-20 2020-08-18 The Regents Of The University Of California moduladores de k-ras
MX2019013562A (es) * 2017-05-19 2020-08-03 Nflection Therapeutics Inc Compuestos de anilina heteroaromatica o fusionados para el tratamiento de trastornos dermicos.
WO2019204449A1 (en) * 2018-04-18 2019-10-24 Theras, Inc. K-ras modulators with a vinyl sulfone moiety
CN108727309B (zh) * 2018-06-20 2023-04-07 天津全和诚科技有限责任公司 一种3-氧杂环丁烷羧酸的合成方法

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383A (en) 1846-02-10 Improvement in condensing steam and feeding steam-boilers
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
GB2222770B (en) 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
ATE270326T1 (de) 1990-04-04 2004-07-15 Chiron Corp Protease von hepatitis-c-virus
DE69434931T2 (de) 1993-04-02 2007-11-22 Rigel Pharmaceuticals, Inc., South San Francisco Methode zur selektiven inaktivierung der viralen replication
IT1272179B (it) 1994-02-23 1997-06-16 Angeletti P Ist Richerche Bio Metodologia per riprodurre in vitro l'attivita' proteolitica della proteasi ns3 del virus hcv.
US5703116A (en) 1995-04-18 1997-12-30 Geron Corporation Telomerase Inhibitors
US5861267A (en) 1995-05-01 1999-01-19 Vertex Pharmaceuticals Incorporated Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity
EP0859833B1 (en) 1995-09-27 2006-03-01 Emory University Recombinant hepatitis c virus rna replicase
US5759795A (en) 1996-03-08 1998-06-02 Schering Corporation Assay for determining inhibitors of ATPase
JP2001514508A (ja) 1997-03-05 2001-09-11 ユニバーシティー オブ ワシントン C型肝炎ウイルスの複製を選択的に抑制する薬剤を同定するための新規なスクリーニング法
US6228576B1 (en) 1997-12-11 2001-05-08 Smithkline Beecham Corporation Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
JPWO2002051849A1 (ja) 2000-12-26 2004-04-22 第一製薬株式会社 Cdk4活性阻害剤
US6951848B2 (en) 2001-03-12 2005-10-04 Millennium Pharmaceuticals, Inc., Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
US7429593B2 (en) 2001-09-14 2008-09-30 Shionogi & Co., Ltd. Utilities of amide compounds
WO2004078163A2 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
EP1558252B1 (en) 2002-08-02 2007-10-10 Merck & Co., Inc. Substituted furo [2,3-b]pyridine derivatives
WO2004014852A2 (en) 2002-08-12 2004-02-19 Bristol-Myers Squibb Company Iminothiazolidinones as inhibitors of hcv replication
EP1560582A4 (en) 2002-10-09 2008-03-12 Scios Inc AZAINDOL DERIVATIVES AS INHIBITORS OF THE p38 KINASE
CN1731993A (zh) 2002-11-01 2006-02-08 维洛药品公司 苯并呋喃化合物、组合物以及治疗和预防丙型肝炎病毒感染及相关疾病的方法
MXPA05010802A (es) 2003-04-25 2005-12-14 Univ Cardiff Compuestos heterociclicos para el uso en el tratamiento de infecciones virales.
JP4836788B2 (ja) 2003-07-23 2011-12-14 エグゼリクシス, インコーポレイテッド 未分化リンパ腫キナーゼ変調因子及びその使用法
CA2534649A1 (en) 2003-08-01 2005-02-10 Genelabs Technologies, Inc. Bicyclic imidazol derivatives against flaviviridae
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
TW200528459A (en) 2004-01-06 2005-09-01 Achillion Pharmaceuticals Inc Azabenzofuran substituted thioureas; inhibitors of viral replication
JP2007529422A (ja) 2004-01-29 2007-10-25 エリクシアー ファーマシューティカルズ, インコーポレイテッド 抗ウイルス治療
WO2005080377A1 (ja) 2004-02-20 2005-09-01 Kirin Beer Kabushiki Kaisha TGFβ阻害活性を有する化合物およびそれを含んでなる医薬組成物
JPWO2005082905A1 (ja) 2004-02-26 2007-08-02 協和醗酵工業株式会社 二環性複素環化合物
JP4604086B2 (ja) 2004-05-07 2010-12-22 エグゼリクシス, インコーポレイテッド Rafモジュレーターおよびその使用方法
CA2571881A1 (en) 2004-06-22 2006-01-26 Andreas P. Termin Heterocyclic derivatives for modulation of calcium channels
TW200618800A (en) 2004-08-03 2006-06-16 Uriach Y Compania S A J Heterocyclic compounds
GB0420719D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
MX2007004783A (es) 2004-10-21 2007-05-11 Pfizer Inhibidores de la proteasa del virus de la hepatitis c, y composiciones y tratamientos que los usan.
US20070128270A1 (en) 2005-11-10 2007-06-07 Wyeth Pharmaceutical formulations containing 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-n-methyl-1-benzofuran-3-carboxamide and method of making the same
US20070208053A1 (en) 2006-01-19 2007-09-06 Arnold Lee D Fused heterobicyclic kinase inhibitors
EP2044061A2 (en) 2006-07-20 2009-04-08 Mehmet Kahraman Benzothiophene inhibitors of rho kinase
EP2094692B1 (en) 2006-11-01 2012-11-28 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof
US8198311B2 (en) 2006-11-01 2012-06-12 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
CN101687789A (zh) 2007-02-12 2010-03-31 因特蒙公司 C型肝炎病毒复制的新颖抑制剂
JPWO2008108309A1 (ja) 2007-03-02 2010-06-17 協和発酵キリン株式会社 縮環ピリジン誘導体
PE20090142A1 (es) 2007-04-11 2009-02-19 Merck & Co Inc Derivados de furo[2,3-b] piridina sustituidos como moduladores del receptor canabinoide-1
GB0707000D0 (en) 2007-04-12 2007-05-30 Istituto Di Ricerche D Biolog Antiviral agents
KR20100016620A (ko) 2007-04-23 2010-02-12 얀센 파마슈티카 엔.브이. 속해리성 도파민 2 수용체 길항제로서의 4-알콕시피리다진 유도체
NZ582096A (en) 2007-06-29 2012-05-25 Gilead Sciences Inc Antiviral compounds that inhibit hepatitis c virus (hcv)
WO2009027732A1 (en) 2007-08-24 2009-03-05 Astrazeneca Ab 5-6-bicyclic heteroaromatic compounds with antibacterial activity
WO2009041591A1 (ja) 2007-09-28 2009-04-02 Kyowa Hakko Kirin Co., Ltd. 縮環ピリジン誘導体
EP2245023B1 (en) 2008-02-14 2011-12-28 F. Hoffmann-La Roche AG Heterocyclic antiviral compounds
WO2009137500A1 (en) 2008-05-05 2009-11-12 Wyeth 6-substituted benzofuran compounds to treat infection with hepatitis c virus
US8546410B2 (en) 2008-05-05 2013-10-01 Abbvie Inc. Heteroaryl-fused macrocyclic pyrimidine derivatives
US8198449B2 (en) 2008-09-11 2012-06-12 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8048887B2 (en) 2008-09-11 2011-11-01 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C

Similar Documents

Publication Publication Date Title
JP2013527842A5 (https=)
JP6991213B2 (ja) Hbv感染の治療のための新規治療薬
ES2665036T3 (es) Bencilinazoles sustituidos para su uso como inhibidores de BUB1 cinasa en el tratamiento de enfermedades hiperproliferativas
ES2598577T3 (es) Compuestos terapéuticos y métodos de uso relacionados
TWI600654B (zh) 用於治療寄生蟲疾病之化合物及組合物
US5939462A (en) NPY5 receptor antagonists and methods for using same
JP4361727B2 (ja) チロシンキナーゼインヒビターとしてのキノリノン誘導体
KR102271574B1 (ko) 설파모일-아릴아미드 및 b형 간염 치료제로서의 그 용도
JP6571173B2 (ja) 一過性受容体電位a1イオンチャネルの阻害
CN103857288B (zh) 作为激酶抑制剂的氨基-喹啉
TWI699360B (zh) 作爲磷脂醯肌醇3-激酶δ抑制劑的取代嘧啶類化合物及其應用
JP2007505933A5 (https=)
AU2017292758A1 (en) 1,3-dihydroxy-phenyl derivatives useful as immunomodulators
RU2015148359A (ru) Хиназолины и азахиназолины - двойные ингибиторы путей ras/raf/mek/erk и pi3k/akt/pten/mtor
WO2012000304A1 (zh) 杂环炔苯类化合物及其药用组合物和应用
CA2251580A1 (en) Amides as npy5 receptor antagonists
RU2017121044A (ru) Производные амидотиадиазола в качестве ингибиторов надфн-оксидазы
WO2015015318A4 (en) Novel quinazolinones as bromodomain inhibitors
WO2015121812A1 (en) Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use
KR20160033707A (ko) 퀴놀린 유도체
JP2012533630A5 (https=)
RU2007101236A (ru) Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей
JP5687617B2 (ja) 運動障害治療剤
JP2017523977A (ja) 新規なインデン誘導体、その調製方法、及びそれを有効成分として含有する網膜疾患を予防又は処置するための医薬組成物
JP2016514717A5 (https=)